Classification, epidemiology and implications of chronic prostatitis in North America, Europe and Asia
- PMID: 15195020
Classification, epidemiology and implications of chronic prostatitis in North America, Europe and Asia
Abstract
The last decade has seen a resurgence of interest and exciting new research on chronic prostatitis and related syndromes. One important reason for this enthusiasm is the recognition that chronic prostatitis syndromes represent an important worldwide health care problem. New data suggesting that chronic prostatitis syndromes may have important long-term consequences are a second reason for the resurgence of research interest. This article reviews the new classification of chronic prostatitis syndromes. Emphasis is then given to summarizing new data on the epidemiology of chronic prostatitis. We concentrated on population-based studies employing reasonable case-definitions to survey various populations from North America, Europe and Asia. These studies suggest that prostatitis syndromes are common, with 2-10% of adult men suffering from symptoms compatible with chronic prostatitis at any time. Approximately 15% of men suffer from symptoms of prostatitis at some point in their lives. Preliminary epidemiological and biological studies also suggest that chronic prostatitis may be associated with an increased risk for development of benign prostatic hyperplasia and prostate cancer. These findings support the conclusions that chronic prostatitis is an important international health care problem that merits increased priority from clinicians as well as increased clinical and basic science research.
Similar articles
-
Epidemiology of prostatitis: new evidence for a world-wide problem.World J Urol. 2003 Jun;21(2):70-4. doi: 10.1007/s00345-003-0329-0. Epub 2003 Apr 24. World J Urol. 2003. PMID: 12712363 Review.
-
Epidemiologic risk factors for chronic prostatitis.Int J Androl. 2005 Dec;28(6):317-27. doi: 10.1111/j.1365-2605.2005.00560.x. Int J Androl. 2005. PMID: 16300663 Review.
-
Chronic prostatitis: epidemiology and role of infection.Urology. 2002 Dec;60(6 Suppl):8-12; discussion 13. doi: 10.1016/s0090-4295(02)02294-x. Urology. 2002. PMID: 12521579 Review.
-
Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.BJU Int. 2005 Mar;95(4):571-4. doi: 10.1111/j.1464-410X.2005.05341.x. BJU Int. 2005. PMID: 15705082
-
Prostatitis revisited: new definitions, new approaches.Infect Dis Clin North Am. 2003 Jun;17(2):395-409. doi: 10.1016/s0891-5520(03)00003-5. Infect Dis Clin North Am. 2003. PMID: 12848476
Cited by
-
Successful use of a phage endolysin for treatment of chronic pelvic pain syndrome/chronic bacterial prostatitis.Front Med (Lausanne). 2023 Aug 15;10:1238147. doi: 10.3389/fmed.2023.1238147. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37649979 Free PMC article.
-
Case Report: Chronic Bacterial Prostatitis Treated With Phage Therapy After Multiple Failed Antibiotic Treatments.Front Pharmacol. 2021 Jun 10;12:692614. doi: 10.3389/fphar.2021.692614. eCollection 2021. Front Pharmacol. 2021. PMID: 34177601 Free PMC article.
-
Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.Cochrane Database Syst Rev. 2018 May 12;5(5):CD012551. doi: 10.1002/14651858.CD012551.pub3. Cochrane Database Syst Rev. 2018. PMID: 29757454 Free PMC article. Review.
-
Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.Cochrane Database Syst Rev. 2018 Jan 26;1(1):CD012551. doi: 10.1002/14651858.CD012551.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2018 May 12;5:CD012551. doi: 10.1002/14651858.CD012551.pub3. PMID: 29372565 Free PMC article. Updated. Review.
-
Prostatic disease and sexual dysfunction.Korean J Urol. 2011 Jun;52(6):373-8. doi: 10.4111/kju.2011.52.6.373. Epub 2011 Jun 17. Korean J Urol. 2011. PMID: 21750746 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical